Mark M. Davis

Systems and Methods Incorporating Modified T-Cells

ANTIGEN DISCOVERY FOR T CELL RECEPTORS ISOLATED FROM PATIENT TUMORS RECOGNIZING WILD-TYPE ANTIGENS AND POTENT PEPTIDE MIMOTOPES

TOLL-LIKE RECEPTOR AGONIST-NANOPARTICLE VACCINE ADJUVANT

IMMUNOSTIMULATORY TOLL-LIKE RECEPTOR AGONIST-NANOPARTICLE FOR CANCER IMMUNOTHERAPY

DISPLAY OF PEPTIDE-MHC (PMHC) ON MULTIMERIC PROTEIN SCAFFOLDS AND USES THEREOF

SYSTEMS AND METHODS TO MODEL ADAPTIVE IMMUNE RESPONSES

CROSS-REACTIVE EPITOPE FOR MULTIPLE SCLEROSIS

MANIPULATION AND USE OF ANTIGEN-SPECIFIC REGULATORY T CELLS

METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING

Antigen Discovery for T Cell Receptors Isolated from Patient Tumors Recognizing Wild-Type Antigens and Potent Peptide Mimotopes

Polymeric nanoparticles for enhanced cancer immunotherapy

Antigen Discovery for T Cell Receptors Isolated from Patient Tumors Recognizing Wild-Type Antigens and Potent Peptide Mimotopes

HAPLOTYPING OF HLA LOCI WITH ULTRA-DEEP SHOTGUN SEQUENCING

Modulation of T cell signaling threshold and T cell sensitivity to antigens

METHODS FOR DIAGNOSIS OF CELIAC DISEASE

SOFTWARE HAPLOTYING OF HLA LOCI

Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing

Haplotying of HLA loci with ultra-deep shotgun sequencing

Modulation of T cell signaling threshold and T cell sensitivity to antigens

Haplotying of HLA loci with ultra-deep shotgun sequencing

Photocrosslinkable Peptide-MHC Complexes for Antigen-Specific T Cells and Methods of Using the Same

METHOD AND SYSTEM FOR ROBUST AND SENSITIVE ANALYSIS OF BEAD-BASED ASSAYS

Method of assaying an individual for immune impairment

Modulation of T cell signaling threshold and T cell sensitivity to antigens

Modulation of T cell signaling threshold and T cell sensitivity to antigens